Infectious disease specialist says restricting ‘off-label’ use of medication to treat COVID-19 is ‘insane’
Insight from Dr. Stephen Smith, founder of the Smith Center for Infectious Diseases and Urban Health, and Dr. Amesh Adalja, senior scholar at the Johns Hopkins University Center for Health Security.